SAB Biotherapeutics (SABSW) Times Interest Earned (2021 - 2025)
Historic Times Interest Earned for SAB Biotherapeutics (SABSW) over the last 5 years, with Q3 2025 value amounting to -$292.87.
- SAB Biotherapeutics' Times Interest Earned fell 10208.45% to -$292.87 in Q3 2025 from the same period last year, while for Sep 2025 it was -$174.11, marking a year-over-year decrease of 942.46%. This contributed to the annual value of -$134.77 for FY2024, which is 1159.58% down from last year.
- Latest data reveals that SAB Biotherapeutics reported Times Interest Earned of -$292.87 as of Q3 2025, which was down 10208.45% from -$151.25 recorded in Q2 2025.
- In the past 5 years, SAB Biotherapeutics' Times Interest Earned registered a high of $10.82 during Q1 2021, and its lowest value of -$292.87 during Q3 2025.
- Over the past 5 years, SAB Biotherapeutics' median Times Interest Earned value was -$109.56 (recorded in 2024), while the average stood at -$115.96.
- Per our database at Business Quant, SAB Biotherapeutics' Times Interest Earned plummeted by 96034.54% in 2022 and then skyrocketed by 4172.98% in 2024.
- Quarter analysis of 5 years shows SAB Biotherapeutics' Times Interest Earned stood at -$110.81 in 2021, then rose by 19.12% to -$89.62 in 2022, then plummeted by 170.4% to -$242.35 in 2023, then skyrocketed by 41.73% to -$141.22 in 2024, then crashed by 107.39% to -$292.87 in 2025.
- Its Times Interest Earned stands at -$292.87 for Q3 2025, versus -$151.25 for Q2 2025 and -$154.85 for Q1 2025.